Inve US ▾
LNLNSR

LENSAR (LNSR) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Aug 13, 2026

Source: earnings call transcript

LENSAR delivered a strong second quarter, demonstrating resilience and renewed momentum following the terminated merger. The company achieved robust top-line growth, driven by expanding recurring revenue and increased utilization of its ALLY system, leading to record adjusted EBITDA. Management is focused on strategic investments in commercial efforts to further expand its installed base and recurring revenue business, positioning for sustainable long-term growth despite anticipated Q3 seasonality.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.